“We are pleased to report the publication of our recent paper at EMBO Molecular Medicine. The work describes the progress made in gene therapy approach for spastic paraplegia type 47 (SPG47): from discovery to IND-enabling studies including safety and toxicity investigations. Further details about the publications can be accessed via the link: Read the publication here.
Article accepted 19/09/2024
